EdgarLookup
SC 13G/A

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Company
CytomX Therapeutics, Inc.
Filed
May 3, 2021
Accession Number
0000921895-21-001197
View Document ↗ View on SEC.gov ↗